Stay updated on A4250 in Children With PFIC Types 1 or 2 Clinical Trial.
Sign up to get notified when there's something new on the A4250 in Children With PFIC Types 1 or 2 Clinical Trial. page.

Latest updates to the A4250 in Children With PFIC Types 1 or 2 Clinical Trial. page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded detailed endpoints and measurement descriptions for pruritus, sleep, and growth, along with updated timing and PRO/ObsRO instruments; also added sponsor/publications data and update timestamps. Removed the EU/RO primary endpoint definition for pruritus assessments.SummaryDifference2%

- Check20 days agoChange DetectedThese changes are minor metadata updates indicating PubMed-generated publication notes and a page revision tag, and they do not affect core study details such as eligibility criteria, primary outcomes, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check28 days agoChange DetectedRemoved a site-wide funding-status notice. The study details and location information on the page remain unchanged.SummaryDifference0.3%

- Check49 days agoChange DetectedDifference0.3%

- Check70 days agoChange DetectedAdded a government funding lapse notice and a v3.2.0 version tag, replacing the prior v3.1.0.SummaryDifference3%

- Check78 days agoChange DetectedAdds revision tag v3.1.0 and removes several MedlinePlus topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and an older revision tag (v3.0.2).SummaryDifference0.5%

Stay in the know with updates to A4250 in Children With PFIC Types 1 or 2 Clinical Trial.
Enter your email address, and we'll notify you when there's something new on the A4250 in Children With PFIC Types 1 or 2 Clinical Trial. page.